Medical Acupuncture Indarjit Camarillo, CA - 93010

Medical Acupuncture Indarjit is categorized under Acupuncturists in Camarillo, CA and active since 2010.

Medical Acupuncture Indarjit was established in 2010, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Acupuncturists business, which does work in the B2C market, and is classified as a Acupuncturists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Indarjit Singh at the company’s single location by writing to 207 Camino Toluca, Camarillo, California CA 93010 or by phoning (805) 388-8330. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Medical Acupuncture Indarjit
Contact Person: Indarjit Singh
Address: 207 Camino Toluca, Camarillo, California 93010
Phone Number: (805) 388-8330
Website Address: lamermedical.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Acupuncturists
SIC Code: 8049
NAICS Code: 6211110
Share This Business:

Medical Acupuncture Indarjit was started in 2010 to provide professional Acupuncturists under the SIC code 8049 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Indarjit Singh for inquiries that concern Medical Acupuncture Indarjit by calling the company number (805) 388-8330, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical Acupuncture Indarjit can be found at the coordinates 34.225567,-119.075272 as well as the street address 207 Camino Toluca in Camarillo, California 93010.

For its online presence, you may visit Medical Acupuncture Indarjit’s website at lamermedical.com and engage with its social media outlets through on Twitter and on Facebook.